Elemé Medical to Launch SmoothShapes Internationally
As the bane of women the world over, treatment for cellulite is a healthcare holy grail. Elemé Medical has developed the FDA-cleared SmoothShapes system, a […]
Member Spotlight
Could Sumatriptan Oral Spray Relieve Investor’s Headaches?
NovaDel has developed an oral spray technology with applications in a broad range of therapeutic areas and product categories. Spray formulations contain the drug in […]
HemCon Expands Reach with New Licensing Agreement
HemCon has signed an agreement with Institute of Technology Sligo, Ireland, to license a controlled release hydrogen peroxide technology. The technology has broad spectrum antibacterial […]
[Video Profile] Interview with Thomas Harold, Founder & CEO of ScyFIX
Age-Related Macular Degeneration (AMD) is the leading cause of blindness in persons over 50 throughout the western hemisphere. But despite the prevalence and severity of […]
Thermage Q2: Robust Results in Ailing Aesthetics Market
Despite the slowdown seen in the aesthetics market, second quarter revenue at Thermage totaled $17.9 million, a 2% increase over Q2 2007. International revenue increased […]
Clarient Q2 Revenues Up 71%
Not wanting to break a winning streak, Clarient delivered its 16th consecutive quarter of quarterly revenue growth. The company posted revenues of $16.9 million in […]
Chembio Q2 Results: Record Revenues, Net Loss Decreases
Chembio Diagnostics reported second quarter revenues of $2.72 million, an 8.6% increase over Q2 2007 and higher than any previous quarter. The lion’s share of […]
[Video] New Developments at Chembio Diagnostics
Chembio Diagnostics develops, manufactures and markets rapid, point-of-care tests for the detection of HIV 1/ 2, Chagas and Sickle Cell disease as well as other […]
SyntheMed’s REPEL-CV Now Available in Canada
REPEL-CV, SyntheMed’s bioresorbable adhesion barrier film used following cardiac surgery, has received Health Canada approval for use in pediatric patients who undergo open heart procedures. […]
Timothy Sullivan Honored by Medical Device & Diagnostic Industry Magazine
Timothy Sullivan, President and CEO of Mystic Pharmaceuticals, has been recognized by the editors of Medical Device & Diagnostic Industry as one of the magazine’s […]